Numab Therapeutics
Operator of a biopharmaceutical company intended to develop multispecific antibody-based immunotherapies. The company reduces the random nature of the discovery process to predictably yield ready-to-d...
Valuation
$0
Share Price
N/A
Total Raised
$228.1M
Last Round
N/A